Clinical trial
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
NCT04575064 is registered in ClinicalTrials.gov with Professor Dr. Bernd Mühlbauer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
- Lead sponsor
- Professor Dr. Bernd Mühlbauer
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- June 29, 2020
- Completion date
- November 30, 2022
- Enrollment
- 0 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, moderate and severe covid-19, sars-cov-2 infection